LBC
LLY icon

Leigh Baldwin & Co’s Eli Lilly LLY Stock Holding History

Leigh Baldwin & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
1,112
-355
-24% -$363K 0.72% 33
2026
Q1 		$1.35M Buy
1,467
+33
+2% +$33.5K 0.87% 31
2025
Q4 		$1.54M Sell
1,434
-52
-3% -$49.7K 1.01% 23
2025
Q3 		$1.13M Buy
1,486
+407
+38% +$303K 0.64% 36
2025
Q2 		$841K Buy
1,079
+10
+0.9% +$7.77K 0.55% 47
2025
Q1 		$883K Hold
1,069
– – 0.71% 38
2024
Q4 		$825K Buy
+1,069
New +$885K 0.7% 40

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Leigh Baldwin & Co's LLY Position: Q2 2026 in Review

Leigh Baldwin & Co reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $363K and leaving 1,112 shares worth $1.33M. The position accounts for 0.72% of the portfolio, ranked #33.

Leigh Baldwin & Co first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.54M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Leigh Baldwin & Co held 1,112 shares of Eli Lilly worth $1.33M as of Q2 2026.
  • Leigh Baldwin & Co sold 355 Eli Lilly shares in Q2 2026, an estimated $363K.
  • Eli Lilly made up 0.72% of Leigh Baldwin & Co's portfolio in Q2 2026, its #33 holding.
  • Leigh Baldwin & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's Eli Lilly position peaked at $1.54M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.